Brief: Cyclopharm Reports FY Net Loss Attributable A$13.2 Mln
25/02/2025 01:32
Feb 25 (Reuters) - Cyclopharm Ltd CYC.AX :
* FY NET LOSS ATTRIBUTABLE A$13.2 MILLION
* FY REVENUES FROM ORDINARY ACTIVITIES A$27.6 MILLION
Further company coverage: CYC.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Cyclopharm
See all newsAustralia's Cyclopharm rises after Chinese medical groups back its Technegas
Australia's Cyclopharm gains most in 8-months on Technegas rollout deal
Australia's Cyclopharm rises on HY revenue forecast
Brief: Cyclopharm Forecasts 1H Global Revenue Of A$17.1 Million
Brief: Cyclopharm Says David Heaney To Retire As Non-Executive Chair